It is used to downregulate the expression of CXCR4, which leads to the inhibition of the uncontrolled production of a variety of key inflammatory cytokines by monocytes that play a central role in the cytokine storm prompted by SARS-CoV-2 in patients with severe COVID-19 [45]. This evidence concerns the gene CXCR4 and COVID-19.